Rishiroop Ltd’s record is clean on its face: seven years of unqualified audit opinions, though Key Audit Matters on financial instruments were reported in FY22, FY23, FY24, and FY26, and auditor confirmations of no fraud. Two things deserve attention: operating cash flow has persistently lagged reported profits, and promoter-family control is entrenched through a 73.58% block with a father-son board duo and MD remuneration that has risen from ₹85.97 lakh in FY2021-22 to ₹1.24 crore in FY2024-25.
Key findings
- Operating cash flow has persistently lagged reported profits
Minor- Cumulative CFO of ₹40 crore covered only 66% of cumulative EBITDA of ₹61 crore over the ten years to FY2026. In FY2025, CFO was ₹1.37 crore against PAT of ₹10.66 crore, a cash conversion ratio of 0.13x. The Board has approved a ₹35 crore capex plan for a new plastics business line at the Wadivare factory site, while a ₹6.72 crore buyback of 5,37,685 shares at ₹125 per share was completed in October 2021. - Promoter-family control is entrenched through a 73.58% block and a father-son board duo
Minor- Promoters held 73.58% of equity with zero shares pledged. Mr. Arvind M. Kapoor (Chairman) and his son Mr. Aditya A. Kapoor (Managing Director) both serve on the Board. The MD’s total remuneration was ₹85.97 lakh in FY2021-22, rising to ₹1.24 crore in FY2024-25, with a further step-up to a basic salary of ₹8.75 lakh per month by FY2027-28 plus commission. The Nomination and Remuneration Committee, which recommends MD pay, includes the Chairman and father of the MD as a member continuously from FY2020-21 through FY2025-26. - Unqualified audit opinions with Key Audit Matters on financial instruments in most years
Clean- The auditor issued an unqualified opinion on the standalone financial statements for every year from FY20 through FY26. A Key Audit Matter on valuation and classification of financial instruments was reported in FY22, FY23, FY24, and FY26. The auditor reported no material fraud by the Company or on the Company has been noticed or reported during FY22, FY23, FY24, and FY25. The internal financial controls opinion was unqualified in every year from FY20 through FY26.
What to watch
- MD re-appointment and remuneration. Mr. Aditya A. Kapoor’s re-appointment as Managing Director runs to 31 March 2028, with escalating remuneration and commission tied to net profits.
- Non-Executive Director continuation. Mr. Atul R. Shah continues as Non-Executive Director up to the conclusion of the 42nd AGM in calendar year 2027.
- Income-tax appeals. Five disputed income-tax demands for FY2005-06 to FY2011-12 were pending before the Bombay High Court as of March 31, 2026.
- Sales-tax appeals. No sales-tax or central-sales-tax appeals were reported as pending before the Commissioner of Sales Tax (Appeals) as of the FY2025-26 reporting period; the disputed statutory dues disclosed as of March 31, 2026, relate solely to income tax matters pending before the Bombay High Court.
Bottom line: This is a disclosed and audited record with a clean audit trail. The risk sits in two places: the persistent gap between reported profit and cash generation, and a governance structure where the promoter block is dominant and the MD’s pay is recommended by a committee that includes his father. Watch whether the ₹35 crore capex plan improves cash conversion, and whether the MD’s escalating remuneration draws greater scrutiny as the re-appointment term progresses.